Regenerating skeletal muscle in the face of aging and disease

Ravi Jasuja, Nathan K LeBrasseur

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Skeletal muscle is a fundamental organ in the generation of force and movement, the regulation of whole-body metabolism, and the provision of resiliency. Indeed, physical medicine and rehabilitation is recognized for optimizing skeletal muscle health in the context of aging (sarcopenia) and disease (cachexia). Exercise is, and will remain, the cornerstone of therapies to improve skeletal muscle health. However, there are now a number of promising biologic and small molecule interventions currently under development to rejuvenate skeletal muscle, including myostatin inhibitors, selective androgen receptor modulators, and an activator of the fast skeletal muscle troponin complex. The opportunities for skeletal musclebased regenerative therapies and a selection of emerging pharmacologic interventions are discussed in this review.

Original languageEnglish (US)
Pages (from-to)S88-S96
JournalAmerican Journal of Physical Medicine and Rehabilitation
Volume93
Issue number11
DOIs
StatePublished - 2014

Fingerprint

Skeletal Muscle
Myostatin
Sarcopenia
Physical and Rehabilitation Medicine
Cachexia
Troponin
Health
Androgen Receptors
Therapeutics

Keywords

  • Cachexia
  • Frailty
  • Myostatin
  • Physical function
  • Sarcopenia
  • Selective androgen receptor modulators
  • Troponin

ASJC Scopus subject areas

  • Rehabilitation
  • Physical Therapy, Sports Therapy and Rehabilitation
  • Medicine(all)

Cite this

Regenerating skeletal muscle in the face of aging and disease. / Jasuja, Ravi; LeBrasseur, Nathan K.

In: American Journal of Physical Medicine and Rehabilitation, Vol. 93, No. 11, 2014, p. S88-S96.

Research output: Contribution to journalArticle

@article{99c8461089b64c8f99cb6c7f3168e084,
title = "Regenerating skeletal muscle in the face of aging and disease",
abstract = "Skeletal muscle is a fundamental organ in the generation of force and movement, the regulation of whole-body metabolism, and the provision of resiliency. Indeed, physical medicine and rehabilitation is recognized for optimizing skeletal muscle health in the context of aging (sarcopenia) and disease (cachexia). Exercise is, and will remain, the cornerstone of therapies to improve skeletal muscle health. However, there are now a number of promising biologic and small molecule interventions currently under development to rejuvenate skeletal muscle, including myostatin inhibitors, selective androgen receptor modulators, and an activator of the fast skeletal muscle troponin complex. The opportunities for skeletal musclebased regenerative therapies and a selection of emerging pharmacologic interventions are discussed in this review.",
keywords = "Cachexia, Frailty, Myostatin, Physical function, Sarcopenia, Selective androgen receptor modulators, Troponin",
author = "Ravi Jasuja and LeBrasseur, {Nathan K}",
year = "2014",
doi = "10.1097/PHM.0000000000000118",
language = "English (US)",
volume = "93",
pages = "S88--S96",
journal = "American Journal of Physical Medicine and Rehabilitation",
issn = "0894-9115",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

TY - JOUR

T1 - Regenerating skeletal muscle in the face of aging and disease

AU - Jasuja, Ravi

AU - LeBrasseur, Nathan K

PY - 2014

Y1 - 2014

N2 - Skeletal muscle is a fundamental organ in the generation of force and movement, the regulation of whole-body metabolism, and the provision of resiliency. Indeed, physical medicine and rehabilitation is recognized for optimizing skeletal muscle health in the context of aging (sarcopenia) and disease (cachexia). Exercise is, and will remain, the cornerstone of therapies to improve skeletal muscle health. However, there are now a number of promising biologic and small molecule interventions currently under development to rejuvenate skeletal muscle, including myostatin inhibitors, selective androgen receptor modulators, and an activator of the fast skeletal muscle troponin complex. The opportunities for skeletal musclebased regenerative therapies and a selection of emerging pharmacologic interventions are discussed in this review.

AB - Skeletal muscle is a fundamental organ in the generation of force and movement, the regulation of whole-body metabolism, and the provision of resiliency. Indeed, physical medicine and rehabilitation is recognized for optimizing skeletal muscle health in the context of aging (sarcopenia) and disease (cachexia). Exercise is, and will remain, the cornerstone of therapies to improve skeletal muscle health. However, there are now a number of promising biologic and small molecule interventions currently under development to rejuvenate skeletal muscle, including myostatin inhibitors, selective androgen receptor modulators, and an activator of the fast skeletal muscle troponin complex. The opportunities for skeletal musclebased regenerative therapies and a selection of emerging pharmacologic interventions are discussed in this review.

KW - Cachexia

KW - Frailty

KW - Myostatin

KW - Physical function

KW - Sarcopenia

KW - Selective androgen receptor modulators

KW - Troponin

UR - http://www.scopus.com/inward/record.url?scp=84914812786&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84914812786&partnerID=8YFLogxK

U2 - 10.1097/PHM.0000000000000118

DO - 10.1097/PHM.0000000000000118

M3 - Article

C2 - 24879554

AN - SCOPUS:84914812786

VL - 93

SP - S88-S96

JO - American Journal of Physical Medicine and Rehabilitation

JF - American Journal of Physical Medicine and Rehabilitation

SN - 0894-9115

IS - 11

ER -